Skip to main content

previous disabled Page of 4
and
  1. No Access

    Chapter and Conference Paper

    The 10.000/μl Morning Trigger for Prophylactic Platelet Transfusion is Safe: Prospective Experience in 411 AML Patients

    There is an increasing demand for platelet transfusions and it remains an ongoing challenge for most blood centers to maintain an adequate platelet inventory. Platelet transfusions doubled in the US and in Can...

    H. Wandt, M. Frank, Th. Denzel, W. Aulitzky, H. Bodenstein in Acute Leukemias VIII (2001)

  2. No Access

    Article

    Interferon-αWirkung, Indikationen, Therapieüberwachung und Nebenwirkungen

    Die Therapie mit Interferonen, insbesondere Interferon-α, hat in den letzten Jahren in der Behandlung chronischer Virusinfektionen sowie maligner Erkrankungen zunehmende Bedeutung erlangt. Der Behandlungserfol...

    M.R. Kraus, K. Wilms in Der Internist (2000)

  3. No Access

    Chapter

    Philipp Franz von Siebold and His Era — Future Perspectives: Academic Cooperation and Exchange Between the Medical Faculties of the Universities of Würzburg and Leiden and Nagasaki University Medical School

    In commemoration of the 200th anniversary of the birth of Philipp Franz von Siebold a Memorial International Medical Symposium with scientific contributions from the Universities of Nagasaki, Würzburg and Leid...

    K. Wilms in Philipp Franz von Siebold and His Era (2000)

  4. No Access

    Chapter and Conference Paper

    Molecular Pathways of Topoisomerase II Regulation and Consequences for Chemotherapy

    The DNA must be restructured continuously in all living and especially in proliferating cells. Conformational alteration is not only necessary for the constitution of chromosomes in mitosis but also for every ...

    F. Gieseler, F. Boege, B. Ruf, P. Meyer, K. Wilms in Acute Leukemias IV (1994)

  5. No Access

    Chapter and Conference Paper

    Cellular and pharmacokinetic factors which influence genotoxicity of topoisomerase II inhibiting drugs in human leukemia cells

    Multidrug resistance (MDR) is a cellular phenomenon which is defined by simultaneous development of resistance against cytostatic drugs from different chemical classes. The cells might even develop cross-resis...

    F. Gieseler, V. Nüßler, F. Boege, D. Biller, P. Meyer in Cancer Treatment An Update (1994)

  6. No Access

    Article

    Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis

    The controlled clinical trial reported here is part of a multicenter clinical and basic research project, sponsored by the German Federal Minister of Science and Technology, directed by a standing commission o...

    P. H. Hofschneider, U. Winter, E. -M. Lemmel, B. Brölz in Rheumatology International (1992)

  7. No Access

    Article

    Failure to detect any effect of amalgam restorations on peripheral blood lymphocyte populations

    Dental amalgam has been considered to have adverse side effects on the immune system. Reports have been contradictory, indicating both an increase and a decrease in peripheral blood lymphocyte counts associate...

    M. Wilhelm, P. Dünninger, R. Rüppel, H. -P. Tony, K. Wilms in The clinical investigator (1992)

  8. No Access

    Article

    γ/δ Receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis

    Recently we described a cutaneous T-cell lymphoma expressing the γ/δ T-cell receptor [5]. The patient suffering from this lymphoma showed low numbers of myeloid and T cells in peripheral blood, while B and NK ...

    M. Wilhelm, P. Meyer, C. Batram, H. P. Tony, R. Dummer, F. Nestle in Annals of Hematology (1992)

  9. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner in Annals of Hematology (1992)

  10. No Access

    Article

    Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

    Bridget T. Hill, L. K. Hosking, S. McClean in Journal of Cancer Research and Clinical On… (1991)

  11. Chapter and Conference Paper

    Grenzfälle in der internistischen Intensivtherapie

    In Lehrbüchern der Intensivmedizin findet sich im allgemeinen nur der pauschale Hinweis, daß inkurable maligne Grunderkrankungen als Ausschlußkriterium für Reanimationsmaßnahmen zu gelten hätten. Eine angemess...

    G. Ertl, H.-P. Schuster, K. Wilms in Verhandlungen der Deutschen Gesellschaft f… (1991)

  12. No Access

    Article

    Absract

    Marietta Kaszkin, Volker Kinzel, Karl Maly in Journal of Cancer Research and Clinical On… (1991)

  13. No Access

    Chapter

    Interferone bei rheumatischen Erkrankungen

    Die Aufklärung der Pathogenese entzündlich rheumatischer Erkrankungen, speziell der chronischen Polyarthritis (c. P.), und damit eine an der Pathogenese orientierte Therapie, ist bis heute ein ungelöstes Probl...

    T. Stolzenburg, K. Wilms in Interferone (1990)

  14. No Access

    Chapter

    Vermehrung der Erythrozyten

    Bei einer Vermehrung der Erythrozytenzahl bzw. des Hämatokrits sind differentialdiagnostisch ge-geneinander abzugrenzen:

  15. Pseudopolyglobulie (Pseudoerythrozytose oder re-lative Erythroz...

  16. K. Wilms in Differentialdiagnose in der Inneren Medizin (1989)

  17. No Access

    Chapter

    Anämie

    Eine Anämie liegt vor, wenn beim Mann der Hä-moglobinwert unter 14 g/dl, bei der Frau unter 12,5 g/dl beträgt. Die Grenzwerte für die Erythro- zytenzahl liegen bei 4,5.106 bzw. 4.106/μl. Für die Beurteilung des S...

    K. Wilms in Differentialdiagnose in der Inneren Medizin (1989)

  18. No Access

    Chapter

    RETRACTED CHAPTER: Zytokine in der klinischen Anwendung

    Priv. Doz. Dr. P. Meyer, K. Wilms in RETRACTED BOOK: Der Internist (1988)

  19. No Access

    Article

    Book reviews

    K. Wilms, K. Schrör in Blut (1986)

  20. Article

    Lung diseases after bone marrow transplantation

    The case histories of 72 subsequently treated patients — 44 with acute leukemia, 10 with chronic myeloid leukemia, 16 with severe aplastic anemia and 2 with neuroblastoma — were analyzed after bone marrow tran...

    H. Link, U. Reinhard, E. Walter, P. Wernet, E. M. Schneider in Klinische Wochenschrift (1986)

  21. No Access

    Article

    Effektivere Behandlung der Peritonealkarzinose durch intraperitoneale Cis-Diamindichloroplatin (c-DDP)-Gabe mit systemischer Natriumthiosulfatprotektion

    Thirteen patients with cytologically or histologically confirmed ascites from various malignancies have received 37 courses of intraperitoneal cis-platinum (cDDP). The tumor had to be confined to the peritonea...

    H. Rückle, G. Ehninger, F. Jakob, K. Wilms in Klinische Wochenschrift (1986)

  22. No Access

    Article

    Acute folic acid deficiency after bone marrow transplantation

    After bone marrow transplantation (BMT), megaloblastic bone marrow changes are often observed that can only be partially explained by drug effects. Our goal was to find out whether folic acid deficiency repres...

    H. Link, M. Blaurock, P. Wernet, D. Niethammer, K. Wilms in Klinische Wochenschrift (1986)

previous disabled Page of 4